Table 3.
Medical Condition | Therapeutic Regimen | Clinical Endpoint | Outcome | Study Type | Reference |
---|---|---|---|---|---|
Neuropathic pain following colic surgery | An amount of 2.5 mg/kg every 8 h for six days | Managing chronic neuropathic pain | Beneficial | Case report (n = 1) | [45] |
Healthy | An amount of 20 mg/kg, single dose | To assess cardiovascular, sedative and behavioral effects | Nonbeneficial | Randomized, cross-over trial (n = 6) |
[92] |
Temporohyoid osteoarthropathy | An amount of 5 mg/kg every 12 h for 10 weeks as adjunctive therapy | Reducing the violent head shaking | Beneficial | Case report (n = 1) | [44] |
Chronic lameness | An amount of 5–10 mg/kg every 8 h for 14 days | Managing chronic pain | Nonbeneficial | Randomized, cross-over, placebo-controlled, double-blinded trial (n = 6) | [91] |
Chronic lameness | An amount of 20 mg/kg every 12 h for 6.5 days | Managing chronic pain | Potentially beneficial if associated with firocoxib (57 mg/day) | Randomized, cross-over, placebo-controlled, masked trial (n = 14) | [43] |